HI
UTHR icon

HBK Investments’s United Therapeutics UTHR Stock Holding History

HBK Investments’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,005
Closed -$318K – 1023
2016
Q2 		$318K Buy
+3,005
New +$335K ﹤0.01% 838
2016
Q1 		– Sell
-1,500
Closed -$235K – 1131
2015
Q4 		$235K Sell
1,500
-4,300
-74% -$626K ﹤0.01% 900
2015
Q3 		$761K Sell
5,800
-10,200
-64% -$1.64M 0.01% 652
2015
Q2 		$2.78M Buy
+16,000
New +$2.88M 0.03% 331
2014
Q2 		– Sell
-3,100
Closed -$291K – 1049
2014
Q1 		$291K Sell
3,100
-1,900
-38% -$194K 0.01% 793
2013
Q4 		$565K Buy
+5,000
New +$451K 0.01% 623

Other funds holding UTHR

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

HBK Investments's UTHR Position: Q3 2016 in Review

HBK Investments sold out of United Therapeutics (UTHR) in Q3 2016, closing a stake of 3,005 shares — an estimated $318K sold.

HBK Investments first reported a position in UTHR in Q4 2013 and held it in 6 quarters. The position peaked at $2.78M in Q2 2015. 394 funds tracked by Wall St. Rank hold UTHR as of Q3 2016.

  • HBK Investments reported no remaining United Therapeutics position as of Q3 2016 after selling out during the quarter.
  • HBK Investments sold 3,005 United Therapeutics shares in Q3 2016, an estimated $318K.
  • HBK Investments first reported a position in United Therapeutics in Q4 2013 and held it in 6 quarters.
  • HBK Investments's United Therapeutics position peaked at $2.78M in Q2 2015.
  • 394 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2016.

Based on HBK Investments's 13F filing for Q3 2016, filed 14 Nov 2016.